Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Healthcare Biotechnology
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Aeterna Zentaris Announces Departure of Interim Chief Financial Officer

GlobeNewswire December 8, 2017

Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates

Benzinga.com  November 30, 2017

Aeterna Zentaris’ Marketing Authorization Application for Macrilen™ (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency

GlobeNewswire November 27, 2017

Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results

Business Wire November 8, 2017

Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017

Business Wire November 2, 2017

Biotech Stocks on Investors' Radar -- Synthetic Biologics, 22nd Century, Abeona Therapeutics, and Aeterna Zentaris

PR Newswire October 31, 2017

Aeterna Zentaris Announces Appointment of Interim Chief Financial Officer

Business Wire September 25, 2017

Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer

Business Wire September 1, 2017

Investor Network: Aeterna Zentaris Inc. to Host Earnings Call

Accesswire August 11, 2017

IIROC Trade Resumption - Aeterna Zentaris Inc.

Newsfile August 9, 2017

IIROC Trade Resumption - AEZS

Canada NewsWire August 9, 2017

Aeterna Zentaris Engages Advisors and Provides Update to Shareholders

Business Wire August 8, 2017

IIROC Trading Halt - AEZS

Canada NewsWire August 8, 2017

Breakfast Technical Briefing on Biotech Stocks -- CytRx, Aeterna Zentaris, Capricor Therapeutics, and Cymabay Therapeutics

PR Newswire August 8, 2017

Aeterna Zentaris to Announce Second Quarter 2017 Financial and Operating Results on August 10, 2017

Business Wire August 4, 2017

Aeterna Zentaris Commences Legal Action Against David Dodd and Philip Theodore

Business Wire August 3, 2017

Wall Street's M&A Chatter From July 25: Aeterna Zentaris, Rent-A-Center, Michael Kors-Jimmy Choo

Benzinga.com  July 26, 2017

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  July 25, 2017

12 Biggest Mid-Day Losers For Monday

Benzinga.com  July 24, 2017

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  July 21, 2017